Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring (DiTECT-HAT-WP3)
Sponsor: CIRDES
Listed as NCT04099628, this NA trial focuses on African Trypanosomiases and Human African Trypanosomiasis and remains completed. Sponsored by CIRDES, it has been updated 8 times since 2019, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2021 — May 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: PHASE2_PHASE3 → NA
▶ Show 3 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Oct 2019 — Sep 2020 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CIRDES
- Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
- Institut National de Sante Publique
- Institut de Recherche pour le Developpement
- Institute of Tropical Medicine, Belgium
- Ministry of Public Health, Democratic Republic of the Congo
- University of Liverpool
For direct contact, visit the study record on ClinicalTrials.gov .